The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation
Jean-Pierre Evenou(Novartis (Switzerland)), Gottfried Baier(Innsbruck Medical University), Sandra Kaminski, Gabriele Weitz‐Schmidt, Jiří Kovařík(Novartis (Switzerland)), Thomas Gruber, Niκolaus Thuille(Innsbruck Medical University), Christina Lutz‐Nicoladoni, Gerhard Zenke, Natascha Hermann‐Kleiter, Christine Guntermann(Babraham Institute), Thomas Letschka, Kathrin Wagner, Volker Brinkmann(Max Planck Institute for Infection Biology), Harry Towbin, Jürgen Wagner(Vogtland-Klinik), Sylvain Cottens, Karl Welzenbach(Novartis (Switzerland))
Cited by 160
Related Papers
Efficient Aldolase Catalytic Antibodies That Use the Enamine Mechanism of Natural Enzymes
|Science|1995|458
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
|British Journal of Pharmacology|2009|437
Fingolimod provides long‐term protection in rodent models of cerebral ischemia
|Annals of Neurology|2010|278